Clinical Trial Update: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating belinostat plus carboplatin in recurrent or persistent carboplatin/ cisplatin–refractory ovarian epithelial, fallopian tube, or primary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Epithelial Cancer
• Peritoneal Cancer

Drugs mentioned

• Belinostat (belinostat)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brenner Tumor, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-01-21